Nasdaq to Suspend Trading in Pomdoctor Securities for Non-Compliance

Key Facts

1Nasdaq announced its intention to suspend trading in Pomdoctor securities due to non-compliance with listing standards.

Nasdaq announced its intention to suspend trading in Pomdoctor securities due to non-compliance with listing standards. Seeking Alpha reported that the company received a staff determination letter notifying it that trading will be suspended effective October 15, 2026, following a failure to meet the exchange's minimum bid price requirement.

The regulatory action is a direct result of the company's failure to meet continued listing requirements, a move that typically precedes delisting and impacts shareholder liquidity. Regarding the exchange operator's performance, NDAQ closed at $92.37 on October 8, 2026, having traded between a day high of $92.69 and a low of $91.1 during that session.